drugset / Trial / NCT00992147

Safety and Efficacy of Autologous Cultured Adipocytes in Patient With Depressed Scar

NCT00992147 ↗

Phase 2/3 Completed 36 enrolled Anterogen Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

Autologous cultured adipocytes (ANTG-adip) is produced by well-established techniques including cell harvesting from lipoaspirates, expansion of adipose tissue derived stem cells, and differentiation into pure and immature adipocytes. This was an open-label, dose-escalation study. Patients are given subcutaneous injection of ANTG-adip and followed for 12 weeks according to the clinical trial protocol.

Timeline

Start
2004-05
Primary completion
—
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Adipocell Cell therapy — Subcutaneous

Indications

No indication recorded.